drugset / Trial / NCT00132171

Helicobacter Pylori Eradication With a New Sequential Treatment

NCT00132171

Phase 3 Completed 1000 enrolled IRCCS Azienda Ospedaliero-Universitaria di Bologna
RandomizedParallel-groupOpen-labelTreatment

Summary

Eradication rates of Helicobacter pylori (H. pylori) with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. The study aimed to assess the eradication rate of a new sequential treatment regimen compared with conventional triple therapy for the eradication of H. pylori infection.

Timeline

Start
2001-01
Primary completion
Completion
2001-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1 g
Subject Clarithromycin Small molecule 500 mg
Subject Rabeprazole Small molecule 20 mg
Subject tinidazole Small molecule 500 mg